Hypoparathyroidism Treatment Market - Forecast(2021 - 2026)

Report Code: HCR 58610 Report Format: PDF + Excel (Delivery in 48 Hrs)

Hypoparathyroidism Treatment Market Overview

Hypoparathyroidism Treatment Market size is forecast to reach $1.3 billion by 2026, growing at a CAGR of 8.3% during the forecast period 2021-2026. A low level of parathyroid hormone is produced by hypoparathyroidism. Parathyroid hormone maintains and regulates the balance between calcium and phosphorus. The decrease in the calcium level and increase in the phosphorus level in the body is caused by little production of parathyroid hormone in the body that cannot cause any serious problem if diagnosed in the earlier phase. Hypoparathyroidism occurs in adults with a sign as poor tooth development, headaches, and mental disorders. The rising prevalence of autoimmune disease and growing cases of neck surgery are the major factors driving the growth of the market. Extensive cancer radiation treatment on the neck or face and new technology advancements for the treatment of hypoparathyroidism is set to further enhance the overall market development for the Hypoparathyroidism Treatment Market for the period 2021-2026.

Hypoparathyroidism Treatment MarketReport Coverage

The report: “Hypoparathyroidism Treatment Market Forecast (2021-2026)”, by Industry ARC, covers an in-depth analysis of the following segments of the Hypoparathyroidism Treatment Market.

By Diagnosed Type: Low Blood Calcium Levels, Low Blood PTH Levels, and High Blood Phosphorus Levels
By Treatment Type: Tablet, Injection, and Surgery Mode
By Route of Administration: Oral, Parenteral, and Others
By End User: Hospitals, Specialty Clinics, and Others
By Geography: North America (U.S., Canada, Mexico), Europe (Germany, United Kingdom, France, Italy, Spain, Russia, and Rest of Europe), Asia Pacific (China, Japan India, South Korea, Australia, and New Zealand, and Rest of APAC), South America (Brazil, Argentina, and Rest of South America), and Rest of the World (Middle East, and Africa)

Key Takeaways

  • North America dominated the Hypoparathyroidism Treatment Market in 2020 owing to the increasing thyroid-related diseases and increasing initiatives by pharmaceutical organizations to generate novel formulations. The Hypoparathyroidism Treatment Market scope for different regions will be provided in the final report
  • Increasing number of thoracic surgeries, incidences of cancer, and new drug development are likely to aid the market growth of the Hypoparathyroidism Treatment Market.
  • Detailed analysis of the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the Hypoparathyroidism Treatment Market report.
  • Lengthy clinical approval cycles and most trials that do not fulfill treatment guidelines established by regulatory authorities is poised to create hurdles for the Hypoparathyroidism Treatment Market.

Hypoparathyroidism Treatment Market Segment Analysis – By Diagnosed Type

Low Blood Calcium Levels held the largest share in the Hypoparathyroidism Treatment Market in 2020 and are estimated to grow at a CAGR 8.7% during the forecast period 2021-2026. Hypoparathyroidism is a disorder during which the parathyroid glands present within the neck secrete low levels of parathormone and leads to an abnormally low level of calcium in the blood which adversely affects many physiologic processes. Calcium supplies electrical energy that is needed for normal muscle contraction and nervous system functions. Symptoms such as dysfunction of the nerves and muscles arise from hypocalcemia that ranges from mild to severe. Low blood calcium levels are set to the highest growing segment and are estimated to register the highest CAGR over the period 2021-2026.

Hypoparathyroidism Treatment Market Segment Analysis – By Treatment Type

Tablet held the largest share in the Hypoparathyroidism Treatment Market in 2020 and is estimated to grow at a CAGR 7.6% during the forecast period 2021-2026. Tablet for hypoparathyroidism treatment includes oral calcium carbonate tablets. Oral calcium supplements increase calcium levels within the blood and can cause gastrointestinal side effects like constipation in some people. Alfacalcidol and Rocaltrol are the different types of vitamin D tablets that provide calcitriol. Calcitriol is being converted from Alfacalcidol and is used in the treatment of hyperparathyroidism. Surgery mode is set to the highest growing segment and is estimated to register the highest CAGR over the period 2021-2026.

Hypoparathyroidism Treatment Market Segment Analysis – By Geography

North America dominated the Hypoparathyroidism Treatment Market with a major share of 37.4% in 2020. This is attributed to the increasing thyroid-related diseases and increasing initiatives by pharmaceutical organizations to generate novel formulations. An increasing number of thoracic surgeries and incidence of cancer is increasing the growth of the market in this region.

However, Asia Pacific is estimated to grow at a higher CAGR during the forecast period 2021-2026 owing to the increasing initiatives taken by the government to spread awareness and the presence of generic manufacturers. New technology advancements for the treatment of hypoparathyroidism are increasing the growth of the market in this region.

Hypoparathyroidism Treatment Market Revenue Share, By Geography, 2020(%)


Hypoparathyroidism Treatment Market Drivers

Increasing Number of Thoracic Surgeries and Incidence of Cancer

An increasing number of thoracic surgeries and incidence of cancer is increasing the growth of the Hypoparathyroidism Treatment Market. This is attributed to the thyroid or neck surgery that is associated with hypoparathyroidism owing to the damage to the parathyroid glands. 39% of thyroidectomies number have increased which indicates it can become permanent in about 25% of cases. Increasing investments in research and development coupled with the development of biologics is also generating momentum and growth opportunities for the market. DiGeorge syndrome includes symptoms such as congenital heart problems, frequent infections, and cleft palate among others. Thus, increasing the growth of the Hypoparathyroidism Treatment Market during the forecast period 2021-2026.

New Drug Development and Government Support

New drug development and government support are increasing the growth of the Hypoparathyroidism Market. This is attributed to the support to hypoparathyroidism treatment products and initiatives by the government of different countries including financial incentives as well as orphan status. Since there is no treatment for hypoparathyroidism, so symptomatic treatment is the chief goal of hypoparathyroidism treatment and any new hypoparathyroidism treatment drug can witness fast adoption with minimal resources owing to the lack of competition in the market. Thus, increasing the growth of the Hypoparathyroidism Market during the forecast period 2021-2026.

Hypoparathyroidism Treatment Market Challenges

Lengthy Clinical Approval Cycles

Some of the factors that are set to impede the growth of the Ion Exchange Membrane Market are lengthy clinical approval cycles and most trials that do not fulfill treatment guidelines established by regulatory authorities

Hypoparathyroidism Treatment Market Landscape

Product launches, mergers, and acquisitions, joint ventures, and R&D activities are key strategies adopted by players in the Hypoparathyroidism Treatment Market. In 2020, the Hypoparathyroidism Treatment Market share is consolidated by the top ten players present in the market. Hypoparathyroidism Treatment Market, top 10 companies are F Hoffman La Roche Ltd., Shire NPS Pharmaceuticals Inc., Abbvie Inc., Sun Pharmaceuticals Ltd., Teva Pharmaceuticals Ltd., Novartis AG, and Glaxosmith Kline PLC among others.

Related Reports

Neuroblastoma Treatment Market – Forecast (2021 - 2026)

Report Code: HCR 0302

Ultrapure Water Market – Forecast (2021 - 2026)

Report Code: CMR 0188

For more Lifesciences and Healthcare Market reports, please click here

1. Hypoparathyroidism Treatment Market- Overview
    1.1 Definitions and Scope
2. Hypoparathyroidism Treatment Market- Executive Summary
    2.1 Market Revenue and Key Trends by Company
    2.2 Key trends by Diagnosed Type
    2.3 Key trends by Treatment Type
    2.4 Key trends by Route of Administration
    2.5 Key trends by End User
    2.6 Key trends by Geography
3. Hypoparathyroidism Treatment Market– Comparative Analysis
    3.1 Product Benchmarking – Key Companies
    3.2 Financial Analysis – Key Companies
    3.3 Market Value Split by Key Companies
    3.4 Patent Analysis – Key Companies
    3.5 Pricing Analysis
4. Hypoparathyroidism Treatment Market- Startup Companies Scenario Premium
    4.1 Key Startup Company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Venture Capital and Funding Scenario
5. Hypoparathyroidism Treatment Market– Industry Market Entry Scenario Premium Premium
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of Successful Ventures
6. Hypoparathyroidism Treatment Market Forces
    6.1 Market Drivers
    6.2 Market Constraints/Challenges
    6.3 Porters five force model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes
7. Hypoparathyroidism Treatment Market– Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle
8. Hypoparathyroidism Treatment Market– By Diagnosed Type(Market Size –$Million/$Billion)
    8.1 Low Blood Calcium Levels
    8.2 Low Blood PTH Levels
    8.3 High Blood Phosphorus Levels
9. Hypoparathyroidism Treatment Market– By Treatment Type(Market Size –$Million/$Billion)
    9.1 Tablet
    9.2 Injection
    9.3 Surgery Mode
10. Hypoparathyroidism Treatment Market– By Route of Administration(Market Size –$Million/$Billion)
    10.1 Oral
    10.2 Parenteral
    10.3 Others
11. Hypoparathyroidism Treatment Market– By End User(Market Size –$Million/$Billion)
    11.1 Hospitals
    11.2 Specialty Clinics
    11.3 Others
12. Hypoparathyroidism Treatment Market- By Geography(Market Size –$Million/$Billion)
    12.1 North America
        12.1.1 U.S.
        12.1.2 Mexico
        12.1.3 Canada
    12.2 Europe
        12.2.1 U.K.
        12.2.2 France
        12.2.3 Germany
        12.2.4 Italy
        12.2.5 Spain
        12.2.6  Russia
        12.2.7 Rest of Europe
    12.3 Asia Pacific
        12.3.1 China
        12.3.2 India
        12.3.3 Japan
        12.3.4 South Korea
        12.3.5 Australia & New Zealand
        12.3.6 Rest of APAC
    12.4 South America
        12.4.1 Brazil
        12.4.2 Argentina
        12.4.3 Rest of South America
    12.5 Rest of the World
        12.5.1 Middle East
        12.5.2 Africa
13. Hypoparathyroidism Treatment Market- Entropy
14. Hypoparathyroidism Treatment Market– Industry/Segment Competition Landscape Premium
    14.1 Market Share Analysis
        14.1.1 Global Market Share – Key Companies
        14.1.2 Market Share by Region – Key companies
        14.1.3 Market Share by Countries – Key Companies
        14.1.4 Best Practices for Companies
15. Hypoparathyroidism Treatment Market– Key Company List by Country Premium Premium
16. Hypoparathyroidism Treatment Market Company Analysis
    16.1 Company 1
    16.2 Company 2
    16.3 Company 3
    16.4 Company 4
    16.5 Company 5
    16.6 Company 6
    16.7 Company 7
    16.8 Company 8
    16.9 Company 9
    16.10 Company 10
"*Financials for private companies would be provided on a best efforts basis”.

LIST OF TABLES

1.Global Hypoparathyroidism Treatment Market Analysis and Forecasts, By Drug Class Market 2019-2024 ($M)
2.Global Hypoparathyroidism Treatment Market Analysis and Forecasts, By Route of Administration Market 2019-2024 ($M)
3.Global Hypoparathyroidism Treatment Market Analysis and Forecasts, By Distribution Channels Market 2019-2024 ($M)
4.Global Competition Landscape Market 2019-2024 ($M)
5.Global Hypoparathyroidism Treatment Market Analysis and Forecasts, By Drug Class Market 2019-2024 (Volume/Units)
6.Global Hypoparathyroidism Treatment Market Analysis and Forecasts, By Route of Administration Market 2019-2024 (Volume/Units)
7.Global Hypoparathyroidism Treatment Market Analysis and Forecasts, By Distribution Channels Market 2019-2024 (Volume/Units)
8.Global Competition Landscape Market 2019-2024 (Volume/Units)
9.North America Hypoparathyroidism Treatment Market Analysis and Forecasts, By Drug Class Market 2019-2024 ($M)
10.North America Hypoparathyroidism Treatment Market Analysis and Forecasts, By Route of Administration Market 2019-2024 ($M)
11.North America Hypoparathyroidism Treatment Market Analysis and Forecasts, By Distribution Channels Market 2019-2024 ($M)
12.North America Competition Landscape Market 2019-2024 ($M)
13.South America Hypoparathyroidism Treatment Market Analysis and Forecasts, By Drug Class Market 2019-2024 ($M)
14.South America Hypoparathyroidism Treatment Market Analysis and Forecasts, By Route of Administration Market 2019-2024 ($M)
15.South America Hypoparathyroidism Treatment Market Analysis and Forecasts, By Distribution Channels Market 2019-2024 ($M)
16.South America Competition Landscape Market 2019-2024 ($M)
17.Europe Hypoparathyroidism Treatment Market Analysis and Forecasts, By Drug Class Market 2019-2024 ($M)
18.Europe Hypoparathyroidism Treatment Market Analysis and Forecasts, By Route of Administration Market 2019-2024 ($M)
19.Europe Hypoparathyroidism Treatment Market Analysis and Forecasts, By Distribution Channels Market 2019-2024 ($M)
20.Europe Competition Landscape Market 2019-2024 ($M)
21.APAC Hypoparathyroidism Treatment Market Analysis and Forecasts, By Drug Class Market 2019-2024 ($M)
22.APAC Hypoparathyroidism Treatment Market Analysis and Forecasts, By Route of Administration Market 2019-2024 ($M)
23.APAC Hypoparathyroidism Treatment Market Analysis and Forecasts, By Distribution Channels Market 2019-2024 ($M)
24.APAC Competition Landscape Market 2019-2024 ($M)
25.MENA Hypoparathyroidism Treatment Market Analysis and Forecasts, By Drug Class Market 2019-2024 ($M)
26.MENA Hypoparathyroidism Treatment Market Analysis and Forecasts, By Route of Administration Market 2019-2024 ($M)
27.MENA Hypoparathyroidism Treatment Market Analysis and Forecasts, By Distribution Channels Market 2019-2024 ($M)
28.MENA Competition Landscape Market 2019-2024 ($M)

LIST OF FIGURES

1.US Hypoparathyroidism Treatment Market Revenue, 2019-2024 ($M)
2.Canada Hypoparathyroidism Treatment Market Revenue, 2019-2024 ($M)
3.Mexico Hypoparathyroidism Treatment Market Revenue, 2019-2024 ($M)
4.Brazil Hypoparathyroidism Treatment Market Revenue, 2019-2024 ($M)
5.Argentina Hypoparathyroidism Treatment Market Revenue, 2019-2024 ($M)
6.Peru Hypoparathyroidism Treatment Market Revenue, 2019-2024 ($M)
7.Colombia Hypoparathyroidism Treatment Market Revenue, 2019-2024 ($M)
8.Chile Hypoparathyroidism Treatment Market Revenue, 2019-2024 ($M)
9.Rest of South America Hypoparathyroidism Treatment Market Revenue, 2019-2024 ($M)
10.UK Hypoparathyroidism Treatment Market Revenue, 2019-2024 ($M)
11.Germany Hypoparathyroidism Treatment Market Revenue, 2019-2024 ($M)
12.France Hypoparathyroidism Treatment Market Revenue, 2019-2024 ($M)
13.Italy Hypoparathyroidism Treatment Market Revenue, 2019-2024 ($M)
14.Spain Hypoparathyroidism Treatment Market Revenue, 2019-2024 ($M)
15.Rest of Europe Hypoparathyroidism Treatment Market Revenue, 2019-2024 ($M)
16.China Hypoparathyroidism Treatment Market Revenue, 2019-2024 ($M)
17.India Hypoparathyroidism Treatment Market Revenue, 2019-2024 ($M)
18.Japan Hypoparathyroidism Treatment Market Revenue, 2019-2024 ($M)
19.South Korea Hypoparathyroidism Treatment Market Revenue, 2019-2024 ($M)
20.South Africa Hypoparathyroidism Treatment Market Revenue, 2019-2024 ($M)
21.North America Hypoparathyroidism Treatment By Application
22.South America Hypoparathyroidism Treatment By Application
23.Europe Hypoparathyroidism Treatment By Application
24.APAC Hypoparathyroidism Treatment By Application
25.MENA Hypoparathyroidism Treatment By Application